COMP <GO>
CI vs UNH // 10Y YIELD & FRED MACRO BETA
The Cigna Group (NYSE) VS. UnitedHealth Group Incorporated (NYSE) • 15-METRIC TALLY: CI 4
— UNH 11
▲ 10Y YIELD & FRED MACRO BETA LEADER: CI
LAST: $298.23 (-0.06%) • MKT CAP: $78.85B
macro-sensitivity
1.12
LAST: $406.97 (-0.96%) • MKT CAP: $364.66B
macro-sensitivity
0.33
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CI VS. UNH)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CI | UNH | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 21.80% | 88.57% | -66.77 | UNH | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 8.80% | 11.47% | -2.67 | UNH | /roic <GO> |
| EV/EBITDA & P/E Valuation | 6.1x | 16.4x | -10.35 | CI | /valuation <GO> |
| Free Cash Flow Yield | -3.51% | 6.48% | -9.99 | UNH | /fcf-yield <GO> |
| Operating Margin | 3.30% | 4.82% | -1.52 | UNH | /operating-margins <GO> |
| Net Profit Margin | 2.20% | 3.14% | -0.94 | UNH | /net-margins <GO> |
| Revenue Growth (YoY) | 11.20% | 6.46% | +4.74 | CI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.04% | 2.28% | -0.24 | UNH | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.70 | 3.12 | -0.42 | UNH | /balance-sheet <GO> |
| Piotroski F-Score Quality | 5/9 | 7/9 | -2.00 | UNH | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.30% | 6.74% | +0.56 | UNH | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 55.6 | 56.0 | -0.43 | UNH | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 1.12 | 0.33 | +0.79 | CI | /macro-sensitivity <GO> |
| Forward P/E Multiple | 12.3x | 17.1x | -4.79 | CI | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $78.85B | $364.66B | -$285.81B | UNH | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CI REV | UNH REV | CI GROSS % | UNH GROSS % | CI FCF | UNH FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $274.90B | $447.57B | 21.8% | 88.7% | -$2.77B | $16.07B |
| FY 2024 | $247.12B | $400.28B | 26.1% | 88.3% | -$757.4M | $20.70B |
| FY 2023 | $195.26B | $371.62B | 44.0% | 89.6% | $3.03B | $25.68B |
| FY 2022 | — | $324.16B | — | 89.6% | — | $23.40B |
| FY 2021 | — | $287.60B | — | 89.2% | — | $19.89B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CI // BETA 1.12
UNH // BETA 0.33